Sontuzumab

• Target :

  Mucin

• Related Pathways :

  Immunology/Inflammation

• Purity :

  0.95

• Bioactivity :

  Sontuzumab (AS1402) is a humanized monoclonal antibody targeting MUC1 that binds to the extracellular MUC1 peptide sequence PDTR (Kd?1 nM) and can be used for breast cancer research.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  372075-37-1